Clinical Trial Update: A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update for customizing ibrutinib treatment regimens in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Ibrutinib (ibrutinib)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma | Phase 2 | Status: RECRUITING